Elected officials at all levels are responsible for representing the interests of their constituents. Write to your elected officials to make sure they hear from you!
Read More »We’re Speaking Out on Health Issues
NCHR scientists and health policy experts provide written and oral statements on a wide range of topics.
Here are many of the ways we have been Speaking Out on Health Policy Issues for the last few years. Whether the topic is legislation intended to cure diseases, proposed bans on BPA or other chemicals that disrupt your hormones, the importance of including women, people of color, and patients over 65 in clinical trials, or many other topics, you’ll gain a better understanding of our evidence-based analyses by reading these letters, statements, and testimony.
Here are the ways we have been Speaking out on Medical Treatments and Products, such as prescription drugs and medical devices that the FDA is considering approving, or is considering taking off the market because of serious risks. Whether the topic is Chantix, Addyi, Yaz, Essure, or medical products you’ve never heard of, you can find out more about what is known and not known about the safety and effectiveness of a wide range of products by looking through this section of our website.
Calling Policy Makers
Elected officials at all levels are responsible for representing the interests of their constituents. Your elected officials must hear from you!
Read More »Concerns with the 21st Century Cures Act
This bill greatly benefits the pharmaceutical industry, medical device manufacturers, home health care companies and others. But by lowering standards for drugs and devices, it is likely to add billions to the cost of Medicare and all health programs without benefiting most patients.
Read More »Statement of NCHR President on Introduction of Prescription Drug Affordability Act of 2015
NCHR Testimony at FDA on the Reauthorization of the Medical Device User Fee Act (MDUFA)
July 13, 2015. MDUFA should protect the public health by improving the safety and efficacy of all medical products, whether PMA or 510(k).
Read More »